{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:55:38Z","timestamp":1785182138880,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["ANRS0512b"],"award-info":[{"award-number":["ANRS0512b"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10461-025-04729-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:36:39Z","timestamp":1745962599000},"page":"2711-2727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Competing Risks Duration Model to Study PrEP Discontinuation Among MSM in France: The ERAS 2023 Study"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8091-8345","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Boutet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-0233","authenticated-orcid":false,"given":"Marion","family":"Di Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-8020","authenticated-orcid":false,"given":"Bruno","family":"Spire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-9108","authenticated-orcid":false,"given":"Annie","family":"Velter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7318-6596","authenticated-orcid":false,"given":"Luis","family":"Sagaon-Teyssier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"4","key":"4729_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2352-3018(22)00030-3","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li C, Xu J, Hu Z, Rutstein SE, Tucker JD, et al. Discontinuation, suboptimal adherence, and re-initiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV. 2022;9(4):e254\u201368.","journal-title":"Lancet HIV"},{"key":"4729_CR2","unstructured":"2024 global AIDS report\u2014the urgency of now: AIDS at a crossroads. Disponible. https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024 Accessed 13 Sept 2024"},{"key":"4729_CR3","unstructured":"World Health Organization. (2012) Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects, Geneva: World Health Organization; Disponible sur: https:\/\/iris.who.int\/handle\/10665\/75188 Accessed 9 Sept 2024"},{"issue":"7","key":"4729_CR4","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2352-3018(16)30036-4","volume":"3","author":"JA Smith","year":"2016","unstructured":"Smith JA, Anderson SJ, Harris KL, McGillen JB, Lee E, Garnett GP, et al. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study. Lancet HIV. 2016;3(7):e289\u201396.","journal-title":"Lancet HIV"},{"issue":"27","key":"4729_CR5","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"10013","key":"4729_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"issue":"23","key":"4729_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"9","key":"4729_CR8","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","volume":"4","author":"JM Molina","year":"2017","unstructured":"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402\u201310.","journal-title":"Lancet HIV."},{"issue":"8","key":"4729_CR9","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","volume":"9","author":"JM Molina","year":"2022","unstructured":"Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, et al. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Lancet HIV. 2022;9(8):e554\u201362.","journal-title":"Lancet HIV."},{"key":"4729_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12889-021-10174-4","volume":"21","author":"U Koppe","year":"2021","unstructured":"Koppe U, Marcus U, Albrecht S, Jansen K, Jessen H, Gunsenheimer-Bartmeyer B, et al. Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 2021;21:159.","journal-title":"BMC Public Health"},{"key":"4729_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fpubh.2018.00137","volume":"6","author":"KJ Jonas","year":"2018","unstructured":"Jonas KJ, Yaemim N. HIV prevention after discontinuing pre-exposure prophylaxis: conclusions from a case study. Front Public Health. 2018;6:137.","journal-title":"Front Public Health"},{"issue":"2","key":"4729_CR12","doi-asserted-by":"publisher","first-page":"e25250","DOI":"10.1002\/jia2.25250","volume":"22","author":"D Krakower","year":"2019","unstructured":"Krakower D, Maloney KM, Powell VE, Levine K, Grasso C, Melbourne K, et al. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019;22(2):e25250.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"4729_CR13","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2352-3018(20)30203-4","volume":"7","author":"SE Rutstein","year":"2020","unstructured":"Rutstein SE, Smith DK, Dalal S, Baggaley RC, Cohen MS. The Initiation, discontinuation and re-starting of HIV pre-exposure prophylaxis (PrEP): an ongoing evolution of implementation strategies. Lancet HIV. 2020;7(10):e721\u201330.","journal-title":"Lancet HIV"},{"issue":"4","key":"4729_CR14","doi-asserted-by":"publisher","first-page":"e0228620","DOI":"10.1371\/journal.pone.0228620","volume":"15","author":"D Pillay","year":"2020","unstructured":"Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS ONE. 2020;15(4):e0228620.","journal-title":"PLoS ONE"},{"issue":"4","key":"4729_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10461-020-03064-0","volume":"25","author":"M Zarwell","year":"2021","unstructured":"Zarwell M, John SA, Westmoreland D, Mirzayi C, Pantalone DW, Golub S, et al. PrEP uptake and discontinuation among a U.S. National sample of transgender men and women. AIDS Behav. 2021;25(4):1063\u201371.","journal-title":"AIDS Behav"},{"issue":"6","key":"4729_CR16","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10461-022-03911-2","volume":"27","author":"A Rotsaert","year":"2023","unstructured":"Rotsaert A, Reyniers T, Vanhamel J, Van Landeghem E, Vanbaelen T, Van Mieghem H, et al. Putting 2\u20131\u20131 into practice: PrEP users\u2019 knowledge of effectively starting and stopping oral PrEP use. AIDS Behav. 2023;27(6):1793\u20139.","journal-title":"AIDS Behav"},{"key":"4729_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.637869","volume":"3","author":"K Ngure","year":"2021","unstructured":"Ngure K, Thuo N, Ogello V, Kiptinness C, Kamolloh K, Burns BFO, et al. Dynamic perceived HIV risk and sexual behaviors among young women enrolled in a PrEP trial in kenya: a qualitative study. Front Reprod Health. 2021;3: 637869.","journal-title":"Front Reprod Health"},{"issue":"1","key":"4729_CR18","doi-asserted-by":"publisher","first-page":"102733","DOI":"10.1016\/j.bjid.2022.102733","volume":"27","author":"A Echeverr\u00eda-Guevara","year":"2022","unstructured":"Echeverr\u00eda-Guevara A, Coelho LE, Veloso VG, Pimenta MC, Hoagland B, Moreira RI, et al. Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil. Braz J Infect Dis. 2022;27(1):102733.","journal-title":"Braz J Infect Dis"},{"issue":"4","key":"4729_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/apc.2021.0197","volume":"36","author":"T Vanbaelen","year":"2022","unstructured":"Vanbaelen T, Rotsaert A, Jacobs BKM, Florence E, Kenyon C, Vuylsteke B, et al. Why do HIV pre-exposure prophylaxis users discontinue pre-exposure prophylaxis care? A mixed methods survey in a pre-exposure prophylaxis clinic in Belgium. AIDS Patient Care STDs. 2022;36(4):159\u201367.","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"4729_CR20","doi-asserted-by":"publisher","first-page":"e0265434","DOI":"10.1371\/journal.pone.0265434","volume":"17","author":"A Rao","year":"2022","unstructured":"Rao A, Mhlophe H, Comins C, Young K, Mcingana M, Lesko C, et al. Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in eThekwini, South Africa, 2016\u20132020. Oldenburg CE, PLOS ONE. 2022;17(3):e0265434.","journal-title":"Oldenburg CE, PLOS ONE."},{"issue":"Suppl 3","key":"4729_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10461-019-02654-x","volume":"23","author":"CP Rolle","year":"2019","unstructured":"Rolle CP, Onwubiko U, Jo J, Sheth AN, Kelley CF, Holland DP. PrEP implementation and persistence in a county health department setting in Atlanta GA. AIDS Behav. 2019;23(Suppl 3):296\u2013303.","journal-title":"AIDS Behav"},{"issue":"3","key":"4729_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cid\/ciaa037","volume":"72","author":"YLA Huang","year":"2021","unstructured":"Huang YLA, Tao G, Smith DK, Hoover KW. Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012\u20132017. Clin Infect Dis. 2021;72(3):379\u201385.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4729_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1089\/apc.2019.0064","volume":"33","author":"PA Chan","year":"2019","unstructured":"Chan PA, Goedel WC, Nunn AS, Sowemimo-Coker G, Gal\u00e1rraga O, Prosperi M, et al. Potential Impact of interventions to enhance retention in care during real-world HIV pre-exposure prophylaxis implementation. AIDS Patient Care STDs. 2019;33(10):434\u20139.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"4729_CR24","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/QAI.0000000000002625","volume":"87","author":"FK Ongolly","year":"2021","unstructured":"Ongolly FK, Dolla A, Ngure K, Irungu EM, Odoyo J, Wamoni E, et al. \u201cI just decided to stop:\u201d understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya. J Acquir Immune Defic Syndr. 2021;87(1):e150\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"4729_CR25","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10461-020-02807-3","volume":"24","author":"ND Laborde","year":"2020","unstructured":"Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, et al. Understanding PrEP persistence: provider and patient perspectives. AIDS Behav. 2020;24(9):2509\u201319.","journal-title":"AIDS Behav"},{"key":"4729_CR26","doi-asserted-by":"publisher","first-page":"116749","DOI":"10.1016\/j.socscimed.2024.116749","volume":"347","author":"J Sinno","year":"2024","unstructured":"Sinno J, Daroya E, Wells A, Hull M, Lachowsky NJ, Tan DHS, et al. \u201cTo do so in a patient-centred way is not particularly lucrative\u201d: the effects of neoliberal health care on PrEP implementation and delivery. Soc Sci Med. 2024;347:116749.","journal-title":"Soc Sci Med"},{"issue":"4","key":"4729_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10461-017-1675-z","volume":"22","author":"P Peng","year":"2018","unstructured":"Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: a systematic review and meta-analysis. AIDS Behav. 2018;22(4):1063\u201374.","journal-title":"AIDS Behav"},{"issue":"5","key":"4729_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/apc.2018.0289","volume":"33","author":"J Blumenthal","year":"2019","unstructured":"Blumenthal J, Moore DJ, Jain S, Sun X, Ellorin E, Corado K, et al. Recent HIV risk behavior and partnership type predict HIV pre-exposure prophylaxis adherence in men who have sex with men. AIDS Patient Care STDs. 2019;33(5):220\u20136.","journal-title":"AIDS Patient Care STDs"},{"issue":"12","key":"4729_CR29","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1007\/s10461-020-02901-6","volume":"24","author":"PW Colson","year":"2020","unstructured":"Colson PW, Franks J, Wu Y, Winterhalter FS, Knox J, Ortega H, et al. Adherence to pre-exposure prophylaxis in black men who have sex with men and transgender women in a community setting in Harlem. NY AIDS Behav. 2020;24(12):3436\u201355.","journal-title":"NY. AIDS Behav."},{"issue":"3","key":"4729_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/QAI.0000000000002952","volume":"90","author":"ZD Unger","year":"2022","unstructured":"Unger ZD, Golub SA, Borges C, Edelstein ZR, Hedberg T, Myers J. Reasons for PrEP discontinuation after navigation at sexual health clinics: interactions among systemic barriers, behavioral relevance, and medication concerns. JAIDS J Acquir Immune Defic Syndr. 2022;90(3):316.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"issue":"11","key":"4729_CR31","doi-asserted-by":"publisher","first-page":"e0241340","DOI":"10.1371\/journal.pone.0241340","volume":"15","author":"O Nieto","year":"2020","unstructured":"Nieto O, Brooks RA, Landrian A, Cabral A, Fehrenbacher AE. PrEP discontinuation among Latino\/a and black MSM and transgender women: a need for PrEP support services. PLoS ONE. 2020;15(11):e0241340.","journal-title":"PLoS ONE"},{"issue":"1","key":"4729_CR32","doi-asserted-by":"publisher","first-page":"e26056","DOI":"10.1002\/jia2.26056","volume":"26","author":"NA Medland","year":"2023","unstructured":"Medland NA, Fraser D, Bavinton BR, Jin F, Grulich AE, Paynter H, et al. Discontinuation of government subsidized HIV pre-exposure prophylaxis in Australia: a whole-of-population analysis of dispensing records. J Int AIDS Soc. 2023;26(1):e26056.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"4729_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10461-022-03782-7","volume":"27","author":"N Thongsak","year":"2023","unstructured":"Thongsak N, Manojai N, Apiputhipan R, Rongram N, Mattawanon N, Bunyatisai W, et al. Risk factors associated with loss to follow-up among transgender women receiving HIV pre-exposure prophylaxis in Chiang Mai province. Thailand AIDS Behav. 2023;27(2):473\u201383.","journal-title":"Thailand AIDS Behav"},{"issue":"4","key":"4729_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/apc.2022.0004","volume":"36","author":"K Rowe","year":"2022","unstructured":"Rowe K, Theodore DA, Zucker J, Cohensedgh O, LaSota E, Carnevale C, et al. Lost2PrEP: understanding reasons for pre-exposure prophylaxis and sexual health care disengagement among men who have sex with men attending a sexual health clinic at a large urban academic medical center in New York City. AIDS Patient Care STDs. 2022;36(4):153\u20138.","journal-title":"AIDS Patient Care STDs"},{"key":"4729_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae133","author":"N Garofoli","year":"2024","unstructured":"Garofoli N, Siguier M, Robineau O, Valette M, Phung B, Bachelard A, et al. Incidence and factors associated with PrEP discontinuation in France. J Antimicrob Chemother. 2024. https:\/\/doi.org\/10.1093\/jac\/dkae133.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4729_CR36","doi-asserted-by":"publisher","first-page":"ofz101","DOI":"10.1093\/ofid\/ofz101","volume":"6","author":"MA Spinelli","year":"2019","unstructured":"Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, et al. Missed visits associated with future preexposure prophylaxis (PrEP) discontinuation among PrEP users in a municipal primary care health network. Open Forum Infect Dis. 2019;6(4):ofz101.","journal-title":"Open Forum Infect Dis"},{"key":"4729_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S2055-6640(20)30378-2","volume":"4","author":"Z Greenwald","year":"2018","unstructured":"Greenwald Z, Beauchemin M, Benomar K, Landry G, Hamel A, Boissonnault M, et al. High seroconversion rates following PrEP discontinuance in a Montreal clinic. J Virus Erad Mai. 2018;4:12.","journal-title":"J Virus Erad mai"},{"key":"4729_CR38","unstructured":"La HAS favorable \u00e0 la prescription de la PrEP en ville pendant l\u2019urgence sanitaire. Haute Autorit\u00e9 de Sant\u00e9. https:\/\/www.has-sante.fr\/jcms\/p_3263807\/fr\/la-has-favorable-a-la-prescription-de-la-prep-en-ville-pendant-l-urgence-sanitaire Accessed 10 Sept 2024"},{"key":"4729_CR39","unstructured":"Actualit\u00e9 - Suivi de l\u2019utilisation de Truvada ou g\u00e9n\u00e9riques pour une prophylaxie pr\u00e9-exposition (PrEP) au VIH \u00e0 partir du syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) [Internet]. ANSM. https:\/\/ansm.sante.fr\/actualites\/suivi-de-lutilisation-de-truvada-ou-generiques-pour-une-prophylaxie-pre-exposition-prep-au-vih-a-partir-du-systeme-national-des-donnees-de-sante-snds-1 Accessed 13 Sep 2024"},{"key":"4729_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-024-02862-0","author":"C Le Roux","year":"2024","unstructured":"Le Roux C, Tassi MF, Faussat C, Aumond C, Gras G, Stefic K, et al. Factors associated with PrEP persistence and loss of follow-up: a 5-year historic cohort. Arch Sex Behav. 2024. https:\/\/doi.org\/10.1007\/s10508-024-02862-0.","journal-title":"Arch Sex Behav"},{"key":"4729_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/09540121.2020.1739208","volume":"32","author":"L Duchesne","year":"2020","unstructured":"Duchesne L, Lydi\u00e9 N, Velter A. Increase in the overall level of protected anal sex in men who have sex with men in France: results from the repeated cross-sectional survey rapport au sexe, France, 2017\u20132019. AIDS Care. 2020;32:162\u20139.","journal-title":"AIDS Care"},{"key":"4729_CR42","unstructured":"Sant\u00e9 Publique France. Bulletin de Sant\u00e9 Publique National VIH et IST Novembre 2023."},{"issue":"10","key":"4729_CR43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"6","key":"4729_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0197-2456(03)00072-2","volume":"24","author":"KJ Carroll","year":"2003","unstructured":"Carroll KJ. On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials. 2003;24(6):682\u2013701.","journal-title":"Control Clin Trials"},{"issue":"10","key":"4729_CR45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.2011.38.5401","volume":"31","author":"P Marino","year":"2013","unstructured":"Marino P, Luis Sagaon T, Laetitia M, Anne-Gaelle LCS. Sex differences in the return-to-work process of cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31(10):1277\u201384.","journal-title":"J Clin Oncol"},{"key":"4729_CR46","unstructured":"R: The R project for statistical computing. Disponible sur: https:\/\/www.r-project.org\/ Accessed 12 Sept 2024"},{"issue":"8","key":"4729_CR47","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s10461-022-03592-x","volume":"26","author":"I Beesham","year":"2022","unstructured":"Beesham I, Joseph Davey DL, Beksinska M, Bosman S, Smit J, Mansoor LE. Daily oral pre-exposure prophylaxis (PrEP) continuation among women from Durban, South Africa, who initiated PrEP as standard of care for HIV prevention in a clinical trial. AIDS Behav. 2022;26(8):2623\u201331.","journal-title":"AIDS Behav"},{"issue":"1","key":"4729_CR48","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4102\/sajhivmed.v23i1.1405","volume":"23","author":"LG Bekker","year":"2022","unstructured":"Bekker LG, Giovenco D, Baral S, Dominguez K, Valencia R, Sanchez T, et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. South Afr J HIV Med. 2022;23(1):1405.","journal-title":"South Afr J HIV Med."},{"issue":"2","key":"4729_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11904-016-0308-x","volume":"13","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, et al. Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings. Curr HIV\/AIDS Rep. 2016;13(2):116\u201324.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"7","key":"4729_CR50","doi-asserted-by":"publisher","first-page":"e040734","DOI":"10.1136\/bmjopen-2020-040734","volume":"10","author":"K Ming","year":"2020","unstructured":"Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, et al. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020;10(7):e040734.","journal-title":"BMJ Open"},{"issue":"2","key":"4729_CR51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciy160","volume":"67","author":"LK Rusie","year":"2018","unstructured":"Rusie LK, Orengo C, Burrell D, Ramachandran A, Houlberg M, Keglovitz K, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012\u20132017: are quarterly visits too much? Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;67(2):283\u20137.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"2","key":"4729_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25252","volume":"22","author":"KC Coy","year":"2019","unstructured":"Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. J Int AIDS Soc F\u00e9vr. 2019;22(2): e25252.","journal-title":"J Int AIDS Soc F\u00e9vr"},{"issue":"9","key":"4729_CR53","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1097\/OLQ.0000000000000823","volume":"45","author":"JC Dombrowski","year":"2018","unstructured":"Dombrowski JC, Golden MR, Barbee LA, Khosropour CM. Patient disengagement from an HIV pre-exposure prophylaxis program in a sexually transmitted disease clinic. Sex Transm Dis. 2018;45(9):e62\u20134.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"4729_CR54","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1007\/s10461-018-2045-1","volume":"22","author":"THF Whitfield","year":"2018","unstructured":"Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men. AIDS Behav. 2018;22(11):3566\u201375.","journal-title":"AIDS Behav"},{"key":"4729_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12645","author":"JD Sharpe","year":"2022","unstructured":"Sharpe JD, Sanchez TH, Siegler AJ, Guest JL, Sullivan PS. Association between the geographic accessibility of PrEP and use of PrEP among MSM in nonurban areas. J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc. 2022. https:\/\/doi.org\/10.1111\/jrh.12645.","journal-title":"J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc."},{"key":"4729_CR56","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1186\/s12889-024-19198-y","volume":"24","author":"D Schmidt","year":"2024","unstructured":"Schmidt D, Duport Y, Kollan C, Marcus U, Iannuzzi S, von Kleist M. Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany. BMC Public Health. 2024;24:1691.","journal-title":"BMC Public Health"},{"key":"4729_CR57","unstructured":"Acc\u00e8s aux soins: les in\u00e9galit\u00e9s territoriales s\u2019aggravent| vie-publique.fr. Disponible sur: 2024 https:\/\/www.vie-publique.fr\/en-bref\/294142-acces-aux-soins-les-inegalites-territoriales-saggravent Accessed 16 Sep 2024"},{"issue":"5","key":"4729_CR58","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav mai. 2017;21(5):1256.","journal-title":"AIDS Behav mai"},{"issue":"5","key":"4729_CR59","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778.","journal-title":"Adv Ther"},{"key":"4729_CR60","first-page":"004695802110176","volume":"58","author":"RL Cooper","year":"2021","unstructured":"Cooper RL, Juarez PD, Morris MC, Ramesh A, Edgerton R, Brown LL, et al. Recommendations for increasing physician provision of pre-exposure prophylaxis: implications for medical student training. Inq J Med Care Organ Provis Financ. 2021;58:00469580211017666.","journal-title":"Inq J Med Care Organ Provis Financ."},{"key":"4729_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.prps.2018.08.001","author":"M Di Ciaccio","year":"2019","unstructured":"Di Ciaccio M, Puppo C, Rojas Castro D, Tremblay C, Cotte L, Pialoux G, et al. Accompagnement m\u00e9dical et communautaire dans un essai de pr\u00e9vention biom\u00e9dicale: vers une nouvelle forme d\u2019\u00e9ducation? Prat Psychol. 2019. https:\/\/doi.org\/10.1016\/j.prps.2018.08.001.","journal-title":"Prat Psychol"},{"key":"4729_CR62","doi-asserted-by":"crossref","unstructured":"Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Pr\u00e9au M, et al. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 2016 [cit\u00e9 24 oct 2024]; Disponible sur: https:\/\/shs.hal.science\/halshs-01562511","DOI":"10.1080\/09540121.2016.1146653"},{"issue":"7","key":"4729_CR63","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s10461-016-1415-9","volume":"20","author":"ML Mehrotra","year":"2016","unstructured":"Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, et al. The effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: a marginal structural model analysis of the iPrEx OLE study. AIDS Behav juill. 2016;20(7):1527\u201334.","journal-title":"AIDS Behav juill"},{"key":"4729_CR64","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1186\/s12889-022-14279-2","volume":"22","author":"PA Shuper","year":"2022","unstructured":"Shuper PA, Varatharajan T, Kinitz DJ, Gesink D, Joharchi N, Bogoch II, et al. Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation. BMC Public Health. 2022;22:1875.","journal-title":"BMC Public Health"},{"issue":"9","key":"4729_CR65","first-page":"1367","volume":"34","author":"MD Ciaccio","year":"2020","unstructured":"Ciaccio MD, Sagaon-Teyssier L, Mimi M, Suzan-Monti M, Proti\u00e8re C, Castro DR, et al. What are the situational and behavioral factors associated with condomless anal sex without pre-exposure prophylaxis in MSM? AIDS Off J Int AIDS Soc. 2020;34(9):1367.","journal-title":"AIDS Off J Int AIDS Soc"},{"issue":"6","key":"4729_CR66","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1007\/s10461-022-03936-7","volume":"27","author":"NS Triplett","year":"2023","unstructured":"Triplett NS, Roberts ST, Hartmann M, Wagner D, Reddy KR, Mathebula F, et al. Examining associations between mental health, IPV exposure, HIV risk behaviors, and PrEP use in South African women: an analysis of data from the charisma study. AIDS Behav. 2023;27(6):2030\u201340.","journal-title":"AIDS Behav"},{"issue":"2","key":"4729_CR67","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10461-020-03004-y","volume":"25","author":"SM Wood","year":"2021","unstructured":"Wood SM, Morales KH, Metzger D, Davis-Vogel A, Fiore D, Petsis D, et al. Mental health, social influences, and HIV pre-exposure prophylaxis (PrEP) utilization among men and transgender individuals screening for HIV prevention trials. AIDS Behav f\u00e9vr. 2021;25(2):524.","journal-title":"AIDS Behav f\u00e9vr"},{"issue":"2","key":"4729_CR68","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/ije\/dym038","volume":"36","author":"O Lundberg","year":"2007","unstructured":"Lundberg O. Social inequalities in health. New evidence and policy implications. Int J Epidemiol. 2007;36(2):474\u20135.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4729_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.socscimed.2012.02.031","volume":"75","author":"JP Mackenbach","year":"2012","unstructured":"Mackenbach JP. The persistence of health inequalities in modern welfare states: the explanation of a paradox. Soc Sci Med. 2012;75(4):761\u20139.","journal-title":"Soc Sci Med"},{"key":"4729_CR70","doi-asserted-by":"publisher","first-page":"110706","DOI":"10.1016\/j.jpsychores.2021.110706","volume":"153","author":"RME Barbek","year":"2022","unstructured":"Barbek RME, Makowski AC, von dem Knesebeck O. Social inequalities in health anxiety: a systematic review and meta-analysis. J Psychosom Res. 2022;153:110706.","journal-title":"J Psychosom Res"},{"issue":"6","key":"4729_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/sextrans-2015-052389","volume":"92","author":"P Prah","year":"2016","unstructured":"Prah P, Hickson F, Bonell C, McDaid LM, Johnson AM, Wayal S, et al. Men who have sex with men in Great Britain: comparing methods and estimates from probability and convenience sample surveys. Sex Transm Infect. 2016;92(6):455.","journal-title":"Sex Transm Infect."},{"issue":"1","key":"4729_CR72","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12889-016-3149-z","volume":"16","author":"CH Mercer","year":"2016","unstructured":"Mercer CH, Prah P, Field N, Tanton C, Macdowall W, Clifton S, et al. The health and well-being of men who have sex with men (MSM) in Britain: evidence from the third national survey of sexual attitudes and lifestyles (Natsal-3). BMC Public Health. 2016;16(1):525.","journal-title":"BMC Public Health"},{"issue":"4","key":"4729_CR73","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13178-019-00413-0","volume":"17","author":"P Weatherburn","year":"2020","unstructured":"Weatherburn P, Hickson F, Reid DS, Marcus U, Schmidt AJ. European men-who-have-sex-with-men internet survey (EMIS-2017): design and methods. Sex Res Soc Policy. 2020;17(4):543\u201357.","journal-title":"Sex Res Soc Policy."},{"issue":"2","key":"4729_CR74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0033354920904085","volume":"135","author":"NW Furukawa","year":"2020","unstructured":"Furukawa NW, Smith DK, Gonzalez CJ, Huang YLA, Hanna DB, Felsen UR, et al. Evaluation of algorithms used for PrEP surveillance using a reference population from New York City, July 2016\u2013June 2018. Public Health Rep. 2020;135(2):202.","journal-title":"Public Health Rep"},{"key":"4729_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac038","author":"YLA Huang","year":"2022","unstructured":"Huang YLA, Zhu W, Wiener J, Kourtis AP, Hall HI, Hoover KW. Impact of COVID-19 on HIV preexposure prophylaxis prescriptions in the United States\u2014a time series analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2022. https:\/\/doi.org\/10.1093\/cid\/ciac038.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"9","key":"4729_CR76","doi-asserted-by":"publisher","first-page":"e26175","DOI":"10.1002\/jia2.26175","volume":"26","author":"L de Vos","year":"2023","unstructured":"de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, et al. Factors that influence adolescent girls and young women\u2019s re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa. J Int AIDS Soc. 2023;26(9):e26175.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"4729_CR77","doi-asserted-by":"publisher","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1007\/s10461-025-04836-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04729-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:01:57Z","timestamp":1757692917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04729-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4729"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04729-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10461-025-04836-2","asserted-by":"object"}]},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"5 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10461-025-04836-2","URL":"https:\/\/doi.org\/10.1007\/s10461-025-04836-2","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}